Clinical Trials Browser

INDUSTRY × Neoplasms × talazoparib × Clear all

NCT05097599 2025-01-08

StrataPATH

Phase 2 Terminated

Neoplasms

NCT03343054 2024-08-22

A Phase 1 Study Of Talazoparib, PARP Inhibitor, In Japanese Patients With Advanced Solid Tumors

Phase 1 Completed

28 enrolled 43 charts

Breast Neoplasms, Neoplasms

NCT02921919 2022-08-24

Open-Label Extension and Safety Study of Talazoparib

Phase 2 Completed

120 enrolled 16 charts

Neoplasms